(Q41448994)

30 September 2017

1 reference

title

Sirolimus: a new agent for clinical renal transplantation (English)

1 reference

30 September 2017

1 reference

Kahan BD

1

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

Transplantation Proceedings

30 September 2017

published in

1 reference

30 September 2017

volume

29

1 reference

30 September 2017

issue

1-2

1 reference

30 September 2017

page(s)

48-50

1 reference

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900008-5

7 January 2021

Rapamycin for immunosuppression in organ allografting.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900008-5

7 January 2021

Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900008-5

7 January 2021

Effects of rapamycin in experimental organ allografting

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900008-5

7 January 2021

Rapamycin: a novel immunosuppressive macrolide

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900008-5

7 January 2021

Effects of rapamycin on human HLA-unrestricted cell killing

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900008-5

7 January 2021

Anti-CD28 antibody- and IL-4-induced human T cell proliferation is sensitive to rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900008-5

7 January 2021

In vitro correlates of in vivo therapy with cyclosporine to immunosuppress rejection of heterotopic rat cardiac allografts across strong (RT-1) plus weak (non-RT-1) histocompatibility differences

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900008-5

7 January 2021

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900008-5

7 January 2021

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900008-5

7 January 2021

Evidence that rapamycin rescue therapy delays rejection of major (MHC) plus minor (non-MHC) histoincompatible heart allografts in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900008-5

7 January 2021

The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900008-5

7 January 2021

Sample clean-up and high-performance liquid chromatographic techniques for measurement of whole blood rapamycin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900008-5

7 January 2021

Preclinical evaluation of a new potent immunosuppressive agent, rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900008-5

7 January 2021

The synergistic interactions in vitro and in vivo of brequinar sodium with cyclosporine or rapamycin alone and in triple combination

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2896%2900008-5

7 January 2021

10.1016/S0041-1345(96)00008-5

Identifiers

DOI

1 reference

30 September 2017

1 reference